hsvti_f1
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 7, 2022 (NCT05298254)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Herpes simplex virus (type 1 / strain F)Immunity, active
Herpes simplex virus (type 1 / strain F) immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05989672 | Phase 1 | Aug 8, 2023 | GlaxoSmithKline |
| NCT05298254 | Phase 1/Phase 2 (Phase 2) | Mar 7, 2022 | GlaxoSmithKline |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 2 | 2 | 2022 |
1 organizations
Page 1 / 1